GI & Endoscopy

Earlier this month, the FDA approved Cologuard, the noninvasive stool DNA screening test for colorectal cancer from Exact Sciences. CEO Kevin Conroy shares what he sees as the test's place in colorectal cancer screening and its impact on the GI…

As we approach the 4th quarter of the year, most of our gastroenterologist clients now have a fairly good idea of what their taxable income will be for 2014. If you are like these clients, you may be wondering "is…

Bundled payments, whether maligned or sought after, are coming to healthcare. While this payment model seems relatively new, some programs have been successfully running for years.

Cologuard, a DNA-based colorectal cancer test, recently earned FDA approval. Now, Mayo Clinic will become the first healthcare provider to offer the new test, according to a Post Bulletin report.

Here are 7 gastroenterologists and colorectal surgeons who made headlines within the past two weeks.

Here are 18 gastroenterology-driven ambulatory surgery centers and facilities opened in 2014 thus far.

Mark Gilreath began working in the GI field in 1992. He is now the founder and CEO of EndoChoice, a GI company that boasts a portfolio of more than 600 products.

Konya Keeling-Johnson, MD, has opened the Houston Southwest Colon and Rectal Clinic, according to a yourfortbendnews report.

In November, John Baillie, MD, will join Virginia Commonwealth University in Richmond as director of endoscopy.

Barrett's esophagus, a condition with a recognized association with esophageal adenocarcinoma, may be linked to an increased risk for colonic tumors, according to Medscape article.